Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 4/20 | 0.38 |
| ▸ | MAOB | P27338 | 4/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.35 |
| ▸ | HTR1A | P08908 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 4/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | CRHBP | P24387 | 2/20 | 0.33 |
| ▸ | CRHR2 | Q13324 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | FKBP1A | P62942 | 1/20 | 0.33 |
| ▸ | KDM1A | O60341 | 2/20 | 0.33 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1009707 | 1.00 | MAOA (0.38) | MAOAMAOBPOLBSIGMAR1HTR1A | |
| SCHEMBL1007966 | 1.00 | MAOA (0.38) | MAOAMAOBPOLBSIGMAR1HTR1A | |
| SCHEMBL180960 | 0.98 | MAOA (0.39) | MAOAMAOBPOLBSIGMAR1HTR1A | |
| SCHEMBL706405 | 0.91 | MAOA (0.35) | MAOAMAOBPOLBSIGMAR1HTR1A | |
| SCHEMBL8019177 | 0.90 | MAOA (0.34) | MAOAMAOBPOLBSIGMAR1LMNA | |
| SCHEMBL11267300 | 0.88 | MAOA (0.35) | MAOAMAOBHTR1AKDM1AADRA1D | |
| SCHEMBL3886896 | 0.88 | MAOA (0.39) | MAOAMAOBHTR1AMEN1KMT2A | |
| SCHEMBL3885101 | 0.88 | MAOA (0.35) | MAOAMAOBPOLBHTR1ALMNA | |
| SCHEMBL8678876 | 0.87 | MEN1 (0.36) | MAOAMAOBPOLBSIGMAR1MEN1 | |
| SCHEMBL10974727 | 0.85 | TDP1 (0.33) | MAOAMAOBHTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105037076-B | The method for preparing 2,3,3,3- tetrafluoropropene | 墨西哥化学阿玛科股份有限公司 | 2019-01-01 | — | — | CN | disclosed |
| US-8697923-B2 | Process for the preparation of 2,3,3,3,-tetrafluoropropene (R-1234yf) | MEXICHEM AMANCO HOLDING S.A. DE C.V. (MX) | 2014-04-15 | — | — | US | disclosed |
| US-20110124930-A1 | PROCESS | MEXICHEM AMANCO HOLDING S.A. DE C.V. (MX) | 2011-05-26 | — | — | US | disclosed |
| US-20110118513-A1 | PROCESS | INEOS FLUOR HOLDINGS LIMITED (GB) | 2011-05-19 | — | — | US | disclosed |
| US-20110112340-A1 | PROCESS | MEXICHEM AMANCO HOLDING S.A. DE C.V. (MX) | 2011-05-12 | — | — | US | disclosed |
| US-20110112338-A1 | Process for the Preparation of 2,3,33-Trifluoropropene | MEXICHEM/ AMANCO HOLDING S.A. DE C.V. (MX) | 2011-05-12 | — | — | US | disclosed |
| EP-2297073-A1 | PROCESS FOR THE PREPARATION OF 2, 3, 3, 3-TRIFLUOROPROPENE | Mexichem Amanco Holdings S.A. de C.V. (MX) | 2011-03-23 | — | — | EP | disclosed |
| EP-2294040-A2 | PROCESS FOR THE PREPARATION OF 2,3,3,3-TETRAFLUOROPROPENE | Mexichem Amanco Holdings S.A. de C.V. (MX) | 2011-03-16 | — | — | EP | disclosed |
| EP-2285761-A2 | PROCESS FOR THE PREPARATION OF 1,1,1-TRIFLUORO-2,3-DICHLOROPROPANE | Mexichem Amanco Holdings S.A. de C.V. (MX) | 2011-02-23 | — | — | EP | disclosed |
| EP-2268595-A2 | PROCESS FOR THE PREPARATION OF 2,3,3,3-TETRAFLUOROPROPENE | Mexichem Amanco Holdings S.A. de C.V. (MX) | 2011-01-05 | — | — | EP | disclosed |
| US-20040127461-A1 | Water soluble, randomly substituted partial N-, partial O-acetylated chitosan, preserving compositions containing chitosan, and processes for making thereof | ADJUVANT PHARMACEUTICALS, LLC (US) | 2004-07-01 | — | — | US | disclosed |
| EP-1425310-A2 | WATER SOLUBLE, RANDOMLY SUBSTITUTED PARTIAL N-, PARTIAL O-ACETYLATED CHITOSAN, PRESERVING COMPOSITIONS CONTAINING CHITOSAN, AND PROCESSES FOR MAKING THEREOF | Technology Resource International Corporation (US) | 2004-06-09 | — | — | EP | disclosed |
| US-6716970-B2 | CONTACT LENS PRESERVATIVE SOLUTION | ADJUVANT PHARMACEUTICALS, LLC | 2004-04-06 | — | — | US | disclosed |
| US-20020177577-A1 | Water soluble, randomly substituted partial N-partial O-acetylated chitosan, preserving compositions containing chitosan, and processes for making thereof | ADJUVANT PHARMACEUTICALS, LLC | 2002-11-28 | — | — | US | disclosed |
| WO-2002085951-A2 | WATER SOLUBLE, RANDOMLY SUBSTITUTED PARTIAL N-, PARTIAL O-ACETYLATED CHITOSAN, PRESERVING COMPOSITIONS CONTAINING CHITOSAN, AND PROCESSES FOR MAKING THEREOF | TECHNOLOGY RESOURCE INTERNATIONAL CORPORATION (US) | 2002-10-31 | — | — | WO | disclosed |
| US-20020018732-A1 | Preserving compositions containing chitosan and processes for making water soluble O-acetylated chitosan and chitosan | TECHNOLOGY RESOURCE INTERNATIONAL CORPORATION | 2002-02-14 | — | — | US | disclosed |
| US-5643925-A | COGNITION ACTIVATORS AND NERVE GROWTH FACTORS | SANKYO COMPANY, LIMITED (JP) | 1997-07-01 | — | — | US | disclosed |
| US-5614521-A | NERVE GROWTH FACTOR | SANKYO COMPANY, LIMITED (JP) | 1997-03-25 | — | — | US | disclosed |
| EP-0501656-B1 | New benzene derivatives having (NGF) production-promoting activity | SANKYO CO (JP) | 1997-01-22 | — | — | EP | disclosed |
| EP-0501656-A2 | New benzene derivatives having (NGF) production-promoting activity | Sankyo Company Limited (JP) | 1992-09-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020177577-A1 | Water soluble, randomly substituted partial N-partial O-acetylated chitosan, preserving compositions containing chitosan, and processes for making thereof | PIGS, CSGALNACT1, OGA | MAOA 1608/4885MAOB 1868/4885POLB 959/4885 |
| US-20110124930-A1 | PROCESS | CYP2F1, CYP4F3, CYP4F11 | MAOA 1882/4885MAOB 844/4885POLB 374/4885 |
| US-20110112340-A1 | PROCESS | CYP2F1, CYP4F11, CYP4F2 | MAOA 1349/4885MAOB 912/4885POLB 983/4885 |
| US-20110118513-A1 | PROCESS | DCAF1, CYP4F3, CLTB | MAOA 3903/4885MAOB 2436/4885POLB 511/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.